Esther Rajavelu
Stock Analyst
(n/a)
# 3,404
Out of 4,234 analysts
16
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | n/a | $172.87 | - | 1 | Oct 4, 2021 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Sell | n/a | $41.22 | - | 1 | Aug 19, 2021 | |
| BHVN Biohaven Pharmaceutical Holding Company | Downgrades: Neutral | n/a | $33.94 | - | 4 | Aug 10, 2021 | |
| STOK Stoke Therapeutics | Initiates: Neutral | n/a | $4.20 | - | 1 | May 18, 2021 | |
| DNLI Denali Therapeutics | Initiates: Buy | n/a | $18.77 | - | 1 | May 18, 2021 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | n/a | $51.46 | - | 2 | May 7, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | n/a | $121.45 | - | 1 | Mar 1, 2021 | |
| ORTX Orchard Therapeutics | Maintains: Outperform | n/a | $16.22 | - | 1 | Apr 1, 2020 | |
| EYEN Eyenovia | Downgrades: Perform | n/a | $1.37 | - | 1 | Feb 3, 2020 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Perform | n/a | $24.93 | - | 1 | Dec 13, 2019 | |
| INVA Innoviva | Initiates: Hold | n/a | $14.39 | - | 1 | Nov 20, 2017 | |
| TXMD TherapeuticsMD | Initiates: Buy | n/a | $2.54 | - | 1 | Jul 21, 2017 |